About us

As one of the leading law firms in the South East with offices in London and Watford, we’re big and strong but we’ve not lost our passion – or our friendly face. We work for you but, more importantly, we work with you.

Our 34 Partners bring their expertise to the table. You bring your legal issue. Together we find a bespoke solution that is perfectly tailored to your business or personal life. Our commitment is to delivering the best service – and giving you a lot more than just law is our main aim.

...more

What we are currently discussing

View more topics

Latest news and views

RSS

Claims of long trading history ruled to be misleading – Coys of Kensington Automobiles v ASA, High Court

17 May 2012 | Simon Weinberg

The High Court has upheld an Advertising Standards Authority that someone trading as “Coys” who had claimed to have been “trading since 1919” was misleading, given that the current business had...

Tags on this discussion: advert Advertising Standards Authority CAP code High Court judicial review misleading advertising

Bristol Myers Squibb loses one third of its revenue overnight as Plavix the latest blockbuster drug to fall over the patent cliff

17 May 2012 | Paul Gershlick

Bristol Myers Squibb has lost one third of its revenues overnight, as its anti-platelet therapy, Plavix, has become the latest blockbuster drug of the big pharma companies to see its patent expire. This...

Tags on this discussion: big pharma generic generic drugs generics Intellectual property intellectual property rights IP IPR patent patent cliff Patents pharma pharma product pharma products pharmaceutical pharmaceutical business pharmaceutical company pharmaceutical industry pharmaceutical market pharmaceutical patent pharmaceutical patents pharmaceutical sector

High Court orders that The Pirate Bay should be blocked

17 May 2012 | Simon Weinberg

The High Court recently ruled that both the operators and users of The Pirate Bay file-sharing website were guilty of infringing copyright. That ruling came in response to an application by a number of...

Tags on this discussion: BPI British Phonographic Industry copyright copyright infringement Everything Everywhere file-sharing High Court illegal infringement Intellectual property intellectual property rights Internet Internet service provider IP ISP O2 Online online content Phonographic Performance Ltd PPL Sky TalkTalk The Pirate Bay unauthorised unlawful Virgin Media web web site web sites Website website content websites

Abiraterone drug approval granted by NICE – but at what price?

16 May 2012 | Paul Gershlick

Abiraterone, the new drug that extends the lives of people with advanced prostate cancer by three months, has been approved by the National Institute for Health and Clinical Excellence (NICE). This follows...

Tags on this discussion: drug drug approval drugs innovate innovation medicine medicines National Health Service National Institute for Health and Clinical Excellence NHS NICE pharma pharma product pharma products pharmaceutical business pharmaceutical company pharmaceutical industry pharmaceutical market pharmaceutical products pharmaceutical sector QIPP QIPP Agenda R&D research and development value based pricing VBP

Parliament enquiry report warns of real health risks from delays in medicines

15 May 2012 | Paul Gershlick

Patients in England are suffering from dangerous shortages in supplies of medicines and the cause is wholesalers taking advantage of legitimate rights to parallel import the medicines into other countries...

Tags on this discussion: All Party Pharmacy Group APPG drug drugs export exporter Kevin Barron medicine medicine supply shortage medicines parallel import parallel importing pharma pharma product pharma products pharmaceutical pharmaceutical business pharmaceutical industry pharmaceutical market pharmaceutical products pharmaceutical sector pharmacy Wholesale

E-disclosure – the perils of getting it wrong

15 May 2012 | Justine Ash

The recent case of West African Gas Pipeline Co Limited v Willbros Global Holdings Inc [2012] EWHC 396 (TCC) serves as a robust reminder to litigators that the courts will not tolerate a lackadaisical...

Tags on this discussion: E-Disclosure; disclosure; wasted costs order; West African Gas Pipeline Co Limited;

GPs make mistakes in one in six prescriptions

15 May 2012 | Paul Gershlick

Doctors are making mistakes in an astonishing one in six prescriptions, according to a General Medical Council study of 1,200 patients. The GMC added that many of the mistakes were thankfully either minor...

Tags on this discussion: drug drugs National Health Service NHS pharma pharma product pharma products pharmaceutical pharmaceutical business pharmaceutical company pharmaceutical industry pharmaceutical market pharmaceutical product pharmaceutical products pharmaceutical sector pharmacies pharmacy prescription

Taxation of vouchers for VAT

11 May 2012 | Iain Donaldson

There have been a number of changes in the last week to the taxation of vouchers for VAT. In light of the ECJ decision published on 3 May has caused HMRC to react with some new legislation published...

Aneurin Bevan Health Board promises to clean up data protection practices after sending mental health patient reports to wrong people

10 May 2012 | Paul Gershlick

Aneurin Bevan Health Board has signed written undertakings to the Information Commissioner’s Office, promising to clean up its act after carelessly sending detailed psychological reports of mental health...

Tags on this discussion: data data breach data breaches data controller data loss data protection data protection act Data Protection Act 1998 data protection laws Data Provider data security DPA health board ICO Information Commissioner Information Commissioner's Office Information Commissioner’s Office misuse of data personal data sensitive personal data

Patent cliff takes toll as Pfizer stops marketing world’s biggest selling drug

10 May 2012 | Paul Gershlick

Pfizer has announced that it is stopping marketing its Lipitor product. The cholesterol-lowering drug is the biggest selling drug in the world. But Pfizer is suffering after Lipitor's patent expired a...

Tags on this discussion: big pharma generic generic drugs generics innovate innovation innovative Intellectual property intellectual property rights invention IP IPR patent patent cliff Patents pharma pharma product pharma products pharmaceutical pharmaceutical business pharmaceutical company pharmaceutical industry pharmaceutical market pharmaceutical patent pharmaceutical patents pharmaceutical product pharmaceutical products pharmaceutical sector

View all discussions